InvestorsHub Logo
icon url

mwebb1514

09/01/17 4:11 PM

#74554 RE: JFXL2 #74552

Sounds about right to me. That is my understanding.
icon url

tulla236a

09/01/17 4:44 PM

#74556 RE: JFXL2 #74552

yes exactly. ciab significanly minimizes side effects of drugs which makes it more desirable than some of these new drugs getting approved and makes ciab approval more likely.

don't worry about getting ripped here. speak your mind. everyone has a right to their opinion.

last post, everyone have a glorious weekend and pray for the people down south. they need all of the help they can get.
icon url

PINKribbon

09/01/17 6:22 PM

#74558 RE: JFXL2 #74552

Yes, a delivery system that Janssen, for example, can use for some of its many chemotherapy drugs. :) :) :)
icon url

JimboPMCB

09/02/17 3:01 AM

#74565 RE: JFXL2 #74552

Right on it's a theory
icon url

Mens et Manus

09/02/17 9:25 AM

#74568 RE: JFXL2 #74552

Thanks for your thoughts. Just wanted to add to your comments:

1.CIAB is a delivery system/platform.

2.CIAB contains biologic cells.

3.CIAB has gone thru Phase I and Phase 2 testing. So using the term theory is not correct. It has proven it works. The company needs to do a Pivotol trial to prove it works in a greater population. The same would be true for a big Pharma company.


Step 2 is why we are waiting for the company to submit its IND. It takes time to grow master and working cells.

Now 2 other points:

1. Each day we are closer to the IND submission.
2. Maybe the company will surprise us this month with a pr relating to diabetes and or ascites. They did not hire a new IR company for nothing.